We previously showed that blocking p55PIK-mediated signaling can improve Imatinib response in chronic myeloid leukemia (CML) [19], suggesting that p55PIK may play an important role in IMA-resistance. The gene discussed is PIK3R3; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.